Michael J. Chumley

Michael J. Chumley

Auto-generated profile, based on publicly available information

Michael J. Chumley

Department of Biology

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2009 in The International Journal of Developmental Biology
Verified
Journal Article
Open access
JGJavier García-Ceca
Javier García-Ceca
EJEva Jimenez
Eva Jimenez
DADavid Alfaro
David Alfaro
TGTeresa Cejalvo Goyanes
Teresa Cejalvo Goyanes
MCMichael J. Chumley
Michael J. Chumley
Agustín G. ZapataAgustín G. Zapata
Agustín G. Zapata
In the current study, we extend our own previous results on the thymocyte phenotype of EphB2 and/or EphB3 deficient mice by analyzing the phenotype and the histological organization of their thymic epithelial stroma. All studied adult EphB-deficient thymi showed profound alterations with respect to the wild-type (WT) ones. Each mutant exhibited a specific phenotype, but also showed common features including occurrence of K5+K8+MTS10+ immature medullary epithelial cells, numerous K5-K8-MTS20+ cells and K5+K8+ cells in the thymic cortex and cortical and medullary K5-K8- areas devoid of epithelial cell markers. In addition, comparative analysis of WT and EphB-deficient embryonic and newborn thymi demonstrated that the observed adult phenotype was a consequence of the gradual accumulation of early phenotypic and morphological defects, becoming more severe at the end of embryonic life and in newborn animals. Together, these results confirm a role for EphB2 and EphB3 in thymus morphogenesis. The obtained data are discussed from the point of view of the recognized role played by these two Ephs in the homeostasis of other epithelia and their possible relationships with molecules known to be involved in thymic epithelial cell development.

11 August 2020 in Physiology & Behavior
Verified
Journal Article
Closed access
KBKelly N. Brice
Kelly N. Brice
CHChristopher W. Hagen
Christopher W. Hagen
JPJulia L. Peterman
Julia L. Peterman
JFJohn W Figg
John W Figg
PBPaige N. Braden
Paige N. Braden
GBGary W Boehm
Gary W Boehm

25 February 2025 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PBPaige N Braden-Kuhle
Paige N Braden-Kuhle
VLVivienne A Lacy
Vivienne A Lacy
KBKelly N Brice
Kelly N Brice
MBMorgan E Bertrand
Morgan E Bertrand
HUHatice Buse Uras
Hatice Buse Uras
MCMichael J Chumley
Michael J Chumley
Background: Research suggests that modifying risk factors may prevent or delay up to 40% of dementia cases, including Alzheimer's disease (AD). Thus, understanding the potential of healthful dietary patterns, like the Mediterranean diet (MD), in AD prevention is crucial. While supplementation of individual Mediterranean foods has demonstrated efficacy in reducing AD biomarkers and cognitive impairment in rodents, the effects of a comprehensive MD warrant further investigation. Additionally, while rodent studies often use a “Western diet” as a model for the typical American diet (TAD), these diets generally exceed the macronutrient densities of typical American consumption, particularly in fats and carbohydrates. Objective: To better reflect human diets, we developed two diets for mice that more closely mirrored the macronutrient composition of the traditional MD or the TAD, each with matched macronutrient profiles (50% kcal from carbohydrates, 35% kcal from fat, 15% kcal from protein), and distinct food sources from Mediterranean regions or the U.S., respectively. Methods: Male C57BL/6J mice were randomly assigned to one diet (MD or TAD) at weaning (21 days of age), which they consumed for six months. Results: Compared to the TAD, MD animals had lower body weight, abdominal and hepatic fat, serum TNF-α, and central Aβ 1–42 , while also exhibiting enhanced exploratory behavior, reduced anxiety-like behavior, and preserved spatial memory. The MD also protected against LPS-induced central inflammation and BDNF loss. Conclusions: These findings suggest that a comprehensive MD provides protection against metabolic and AD-related markers in wildtype mice, despite matched caloric availability to the TAD.

19 July 2016 in Behavioural Brain Research
Verified
Journal Article
Closed access
JWJ.D. White
J.D. White
MEM.J. Eimerbrink
M.J. Eimerbrink
HHH.B. Hayes
H.B. Hayes
AHA. Hardy
A. Hardy
EEE.A. Van Enkevort
E.A. Van Enkevort
GBGary W Boehm
Gary W Boehm

6 May 2026 in ACS Applied Bio Materials
Verified
Journal Article
Open access
PSPramita Sharma
Pramita Sharma
AVAlina Valimukhametova
Alina Valimukhametova
NCNatalia Castro-Lopez
Natalia Castro-Lopez
LGLogun Presley K. Gunderson
Logun Presley K. Gunderson
DVDiya Vashani
Diya Vashani
ANAnton Naumov
Anton Naumov
Semiconducting single-walled carbon nanotubes (SWCNTs) are emerging as powerful near-infrared probes for deep-tissue imaging. While SWCNT samples involving multiple chiralities can be seen as a collection of spectrally resolved fluorophores, their multiplex imaging capabilities remain underexplored. This work presents a filter-resolved evaluation of DSPE-mPEG-coated CoMoCAT SWCNTs integrating optical characterization, biodistribution, pharmacokinetics, and toxicity studies in BALB/c mice. Band-pass filters centered at 1000, 1050, and 1100 nm are used to isolate emission from the dominant (6,5) species and coexisting (7,5) and (7,6) chiralities within the NIR-II window. Following intraperitoneal administration, longitudinal whole-body imaging (0.5–24 h) illustrates rapid systemic spread and preferential uptake in reticuloendothelial organs. Ex vivo organ analysis reveals a hierarchy of emission intensities (liver >> spleen >> lung > heart > kidney > brain > thymus) preserved across all three detection channels, suggesting a negligible influence of SWCNT chirality on biodistribution. Serum kinetics show monoexponential decay with an apparent elimination half-life of ∼2.69 h. In a 21-day toxicity study, treated animals maintain stable body mass and normal behavior, organ-level fluorescence returns to the baseline, and H&E sections of the liver, kidney, and lung reveal preserved architecture without inflammatory or fibrotic lesions. Collectively, this work defines an initial in vivo tolerability profile, safe dosing, and imaging conditions for DSPE-mPEG/CoMoCAT SWCNTs and demonstrates that filter-resolved NIR-II fluorescence can be exploited for multiplex tracking of nanotube probes in vivo, providing a foundation for future biosensing and image-guided therapeutic applications.